Time-course of the DSM-5 cannabis withdrawal symptoms in poly-substance abusers

BMC Psychiatry

Volumn 13, Issue , 2013, Pages

  Hesse, Morten ^a   Thylstrup, Birgitte ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Cannabis withdrawal; Poly substance abusers; Withdrawal symptoms

Indexed keywords

CANNABIS;

ADULT; ARTICLE; CANNABIS ADDICTION; CHECKLIST; DETOXIFICATION; DISEASE SEVERITY; DRUG USE; DRUG WITHDRAWAL; DSM-5; FEMALE; HUMAN; LOSS OF APPETITE; MAJOR CLINICAL STUDY; MALE; REHABILITATION CENTER; SELF REPORT; SUBSTANCE ABUSE; TREATMENT DURATION; UNPLEASANT DREAM; VIVID DREAM; WITHDRAWAL SYNDROME;

ADULT; CANNABIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG USERS; FEMALE; HUMANS; IRRITABLE MOOD; MALE; SEVERITY OF ILLNESS INDEX; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 84885358786     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-13-258     Document Type: Article

References (32)

1. Hu X. Benzodiazepine withdrawal seizures and management. J Oklahoma State Med Assoc 2011, 104(2):62-65.
2. Budney AJ, Hughes JR. The cannabis withdrawal syndrome. Curr Opin Psychiatry 2006, 19(3):233-238. 10.1097/01.yco.0000218592.00689.e5, 16612207.
3. APA Diagnostic and Statistical Manual 2013, Arlington: American Psychiatric Association, 5, APA.
4. Carroll KM, Rounsaville BJ, Bryant RA. Should tolerance and withdrawal be required for substance dependence disorders?. Drug & Alcohol Dependence 1994, 36(1):15-22. 10.1016/0376-8716(94)90004-3, 7988354.
5. Budney AJ, Vandrey RG, Hughes JR, Thostenson JD, Bursac Z. Comparison of cannabis and tobacco withdrawal: severity and contribution to relapse. J Subst Abuse Treat 2008, 35(4):362-368. 10.1016/j.jsat.2008.01.002, 18342479.
6. Vandrey RG, Budney AJ, Hughes JR, Liguori A. A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances. Drug Alcohol Depend 2008, 92(1-3):48-54. 2214670, 17643868.
7. Chung T, Martin CS, Cornelius JR, Clark DB. Cannabis withdrawal predicts severity of cannabis involvement at 1-year follow-up among treated adolescents. Addiction 2008, 103(5):787-799. 10.1111/j.1360-0443.2008.02158.x, 18412757.
8. Cornelius JR, Chung T, Martin C, Wood DS, Clark DB. Cannabis withdrawal is common among treatment-seeking adolescents with cannabis dependence and major depression, and is associated with rapid relapse to dependence. Addict Behav 2008, 33(11):1500-1505. 10.1016/j.addbeh.2008.02.001, 2565493, 18313860.
9. Allsop DJ, Norberg MM, Copeland J, Fu S, Budney AJ. The cannabis withdrawal scale development: patterns and predictors of cannabis withdrawal and distress. Drug Alcohol Depend 2011, 119(1-2):123-129. 10.1016/j.drugalcdep.2011.06.003, 21724338.
10. Milin R, Manion I, Dare G, Walker S. Prospective assessment of cannabis withdrawal in adolescents with cannabis dependence: a pilot study. J Am Acad Child Adolesc Psychiatry 2008, 47(2):174-178. 10.1097/chi.0b013e31815cdd73, 18176332.
11. Budney AJ, Moore BA, Vandrey RG, Hughes JR. The time course and significance of cannabis withdrawal. J Abnorm Psychol 2003, 112(3):393-402.
12. Preuss UW, Watzke AB, Zimmermann J, Wong JW, Schmidt CO. Cannabis withdrawal severity and short-term course among cannabis-dependent adolescent and young adult inpatients. Drug Alcohol Depend 2010, 106(2-3):133-141.
13. Budney AJ, Vandrey RG, Hughes JR, Moore BA, Bahrenburg B. Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms. Drug Alcohol Depend 2007, 86(1):22-29. 10.1016/j.drugalcdep.2006.04.014, 16769180.
14. Vandrey R, Stitzer ML, Mintzer MZ, Huestis MA, Murray JA, Lee D. The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users. Drug Alcohol Depen 2013, 128(1-2):64-70.
15. Levin FR, Mariani JJ, Brooks DJ, Pavlicova M, Cheng W, Nunes EV. Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depen 2011, 116(1-3):142-150.
16. Vandrey R, Smith MT, McCann UD, Budney AJ, Curran EM. Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal. Drug Alcohol Depen 2011, 117(1):38-44.
17. Arendt M, Rosenberg R, Foldager L, Sher L, Munk-Jorgensen P. Withdrawal symptoms do not predict relapse among subjects treated for cannabis dependence. Am J Addict 2007, 16(6):461-467. 10.1080/10550490701640985, 18058411.
18. Budney AJ, Hughes JR, Moore BA, Novy PL. Marijuana abstinence effects in marijuana smokers maintained in their home environment. Arch Gen Psychiatry 2001, 58(10):917-924. 10.1001/archpsyc.58.10.917, 11576029.
19. Copersino ML, Boyd SJ, Tashkin DP, Huestis MA, Heishman SJ, Dermand JC, Simmons MS, Gorelick DA. Cannabis withdrawal among non-treatment-seeking adult cannabis users. Am J Addict 2006, 15(1):8-14. 10.1080/10550490500418997, 16449088.
20. Levin KH, Copersino ML, Heishman SJ, Liu F, Kelly DL, Boggs DL, Gorelick DA. Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers. Drug Alcohol Depend 2010, 111(1-2):120-127. 2930056, 20510550.
21. Mennes CE, Ben Abdallah A, Cottler LB. The reliability of self-reported cannabis abuse, dependence and withdrawal symptoms: multisite study of differences between general population and treatment groups. Addict Behav 2009, 34(2):223-226. 10.1016/j.addbeh.2008.10.003, 19004561.
22. Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW. Abstinence symptoms following smoked marijuana in humans. Psychopharmacology (Berl) 1999, 141(4):395-404. 10.1007/s002130050849, 10090647.
23. Kouri EM, Pope HG. Abstinence symptoms during withdrawal from chronic marijuana use. Exp Clin Psychopharmacol 2000, 8(4):483-492.
24. Bolla KI, Lesage SR, Gamaldo CE, Neubauer DN, Wang NY, Funderburk FR, Allen RP, David PM, Cadet JL. Polysomnogram changes in marijuana users who report sleep disturbances during prior abstinence. Sleep Med 2010, 11(9):882-889. 10.1016/j.sleep.2010.02.013, 2938870, 20685163.
25. Orne MT. On the social psychology of the psychological experiment: with particular reference to demand characteristics and their implications. Am Psychol 1962, 17:776-783.
26. Vorspan F, Guillem E, Bloch V, Bellais L, Sicot R, Noble F, Lepine JP, Gorelick DA. Self-reported sleep disturbances during cannabis withdrawal in cannabis-dependent outpatients with and without opioid dependence. Sleep Med 2010, 11(5):499-500. 10.1016/j.sleep.2009.12.001, 2854878, 20138005.
27. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The fifth edition of the addiction severity index. J Subst Abuse Treat 1992, 9(3):199-213. 10.1016/0740-5472(92)90062-S, 1334156.
28. APA Diagnostic and Statistical Manual Text Revision 2000, Washington D. C: American Psychiatric Association, APA.
29. Pedersen MU, Hesse M, Bloomfield K. Abstinence-orientated residential rehabilitation of opioid users in Denmark: do changes in national treatment policies affect treatment outcome?. Scand J Public Health 2011, 39(6):582-589. 10.1177/1403494811407673, 21622678.
30. Schierenbeck T, Riemann D, Berger M, Hornyak M. Effect of illicit recreational drugs upon sleep: cocaine, ecstasy and marijuana. Sleep Medine Reviews 2008, 12(5):381-389.
31. Hart CL. Increasing treatment options for cannabis dependence: a review of potential pharmacotherapies. Drug Alcohol Depend 2005, 80(2):147-159. 10.1016/j.drugalcdep.2005.03.027, 15899556.
32. Winstock AR, Ford C, Witton J. Assessment and management of cannabis use disorders in primary care. BMJ 2010, 340:c1571. 10.1136/bmj.c1571, 20360216.